U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...
"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...
Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...